Chapter 23 - DRUGS: USE OF AMYGDALIN (LAETRILE)
- Section 16-42-23-1 - Health care facilities; restrictions on use
- Section 16-42-23-2 - Disciplinary action against attending physician
- Section 16-42-23-3 - Prescription or administration permitted with written informed request
- Section 16-42-23-4 - Construction of chapter
- Section 16-42-23-5 - Written informed request form
- Section 16-42-23-6 - Regulation of use, sale, prescription, manufacture, or distribution within state
- Section 16-42-23-7 - Required manufacture, sale, distribution, or prescription
- Section 16-42-23-8 - Federal funding of health care facilities